###begin article-title 0
Association of the GSTP1 and NQO1 Polymorphisms and Head and Neck Squamous Cell Carcinoma Risk
###end article-title 0
###begin p 1
###xml 4 9 4 9 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GSTP1</italic>
###xml 14 18 14 18 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NQO1</italic>
###xml 390 395 390 395 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GSTP1</italic>
###xml 410 414 410 414 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NQO1</italic>
###xml 553 554 551 552 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 625 630 623 628 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GSTP1</italic>
###xml 635 639 633 637 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NQO1</italic>
###xml 797 802 795 800 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GSTP1</italic>
###xml 807 811 805 809 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NQO1</italic>
###xml 916 921 914 919 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GSTP1</italic>
###xml 959 963 957 961 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NQO1</italic>
###xml 1101 1102 1099 1100 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1128 1133 1126 1131 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GSTP1</italic>
###xml 1152 1156 1150 1154 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NQO1</italic>
###xml 1242 1247 1240 1245 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GSTP1</italic>
###xml 1252 1256 1250 1254 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NQO1</italic>
###xml 987 994 <span type="species:ncbi:4097">tobacco</span>
###xml 1192 1199 <span type="species:ncbi:4097">tobacco</span>
The GSTP1 and NQO1 have been reported to be associated with an increased risk for smoking related head and neck squamous cell carcinoma (HNSCC). The purpose of this study was to determine the effect of these metabolic gene polymorphisms on the risk of HNSCC. The study population included 294 histologically confirmed HNSCC cases and 333 controls without cancer. Genotyping analysis of the GSTP1 Ile105Val and NQO1 Trp139Arg genes was performed by polymerase chain reaction-based techniques on DNA prepared from peripheral blood. The Mantel-Haenszel chi2 test was used for statistical analysis. The allele frequencies of the GSTP1 and NQO1 polymorphisms were not statistically significant between cases and controls. In analyzing the association between smoking amounts and genetic polymorphisms, GSTP1 and NQO1 polymorphisms were associated with cigarette smoking amounts in cases. G allele containing genotypes in GSTP1 and T allele containing genotypes in NQO1 were associated with a tobacco dose-dependent increase in risk of HNSCC and these genotype distributions were statistically significant (p<0.05). We found that the GSTP1 105Val allele and NQO1 139Arg allele were associated with tobacco dose-dependent increase in risk of HNSCC. GSTP1 and NQO1 genotype polymorphisms may play an important role in the development of smoking related HNSCC.
###end p 1
###begin title 2
INTRODUCTION
###end title 2
###begin p 3
###xml 439 440 439 440 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B1">1</xref>
###xml 587 588 587 588 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B2">2</xref>
###xml 1035 1036 1035 1036 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B3">3</xref>
###xml 178 185 <span type="species:ncbi:4097">tobacco</span>
###xml 345 352 <span type="species:ncbi:4097">tobacco</span>
###xml 661 668 <span type="species:ncbi:4097">tobacco</span>
Head and neck squamous cell carcinoma (HNSCC) which includes cancers of the larynx, pharynx, and oral cavity, show a wide range of geographical variations in incidence. Although tobacco and alcohol consumption are recognized as the major causes of HNSCC, geographic distribution of cancer incidence is not strongly correlated with areas of high tobacco and alcohol consumption. Also, only a small number of smokers actually develop HNSCC (1). This suggests a gene-environmental interaction where host components, likely genetics, have an influential role in the susceptibility to HNSCC (2). The presence of polymorphisms in genes coding for enzymes involved in tobacco-related carcinogen metabolism, such as the glutathione S-transferase (GST) and NAD(P)H:quinone oxidoreductase (NQO) enzymes, could explain this difference in susceptibility. It has recently been suggested that these inherited differences, in the capacity to metabolize such chemicals, are the modifiers of individual susceptibility to environmentally induced HNSCC (3).
###end p 3
###begin p 4
###xml 221 222 221 222 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B4">4</xref>
###xml 224 225 224 225 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B5">5</xref>
###xml 410 415 410 415 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GSTP1</italic>
###xml 625 626 625 626 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B6">6</xref>
###xml 921 922 921 922 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B7">7</xref>
###xml 975 980 975 980 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GSTP1</italic>
###xml 1119 1120 1119 1120 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B8">8</xref>
###xml 1302 1303 1302 1303 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B9">9</xref>
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 507 514 <span type="species:ncbi:4097">tobacco</span>
###xml 599 604 <span type="species:ncbi:9606">human</span>
###xml 698 705 <span type="species:ncbi:4097">tobacco</span>
###xml 1237 1245 <span type="species:ncbi:9606">patients</span>
Human GST enzymes can be subdivided into five main classes, alpha (A), mu (M), pi (P), theta (T), and zeta (Z). Each class includes one or more isoenzymes with different, but sometimes overlapping, substrate specificity (4, 5). As a result of conjugation with glutathione, the potential carcinogens are eliminated and DNA, or other important biomolecules, are protected against damage or adduct formation. The GSTP1 gene encodes for the isoenzyme GSTP1-1. GSTP1-1 is a major enzyme in the detoxification of tobacco-related metabolic products and, quantitatively, the most abundant GST enzyme in the human head and neck area (6). The GSTP1-1 enzyme level has been extensively studied in relation to tobacco-related malignancies. Elevated tissue levels of GSTP1-1 enzyme have been found in stomach, colorectal, bladder, oral, pharynx, larynx, lung, skin, and breast tumors compared with normal tissues of matched controls (7). Ali-Osman et al. have described a polymorphism of GSTP1, resulting from a single base change at codon 105, that produces an enzyme with reduced capacity for detoxifying a number of carcinogens (8). Recently, there have been several reports describing a higher risk of developing HNSCC at pharyngeal locations in patients who are Val homozygous for the GSTP1 Ile105Val variant (9).
###end p 4
###begin p 5
###xml 178 180 178 180 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B10">10</xref>
###xml 665 667 665 667 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B11">11</xref>
###xml 863 865 863 865 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B12">12</xref>
###xml 1027 1031 1027 1031 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NQO1</italic>
###xml 1099 1103 1099 1103 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NQO1</italic>
###xml 1222 1224 1222 1224 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B13">13</xref>
###xml 1225 1227 1225 1227 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B16">16</xref>
###xml 317 325 <span type="species:ncbi:50278|species:ncbi:153742">quinines</span>
###xml 1048 1055 <span type="species:ncbi:4097">tobacco</span>
NQO1 is also a detoxification enzyme that plays a critical role in protecting cells against chemically induced oxidative stress, cytotoxicity, mutagenicity, and carcinogenicity (10). NQO1 protects cells from oxidative damage by preventing the generation of reactive oxygen species through the reduction of endogenous quinines, and by reducing certain environmental carcinogens, such as nitroaromatic compounds, heterocyclic amines, and possibly cigarette smoke condensate. Furthermore, NQO1 reduces the formation of DNA adducts induced by benzo[a]pyrene 3,6-quinone, one of the important carcinogenic polycyclic aromatic hydrocarbons identified in cigarette smoke (11). However, under specific circumstances, metabolism by NQO1 yields more active products that can actually produce reactive oxygen species or undergo rearrangement to generate alkylating species (12). Therefore, NQO1 exerts both beneficial and harmful effects, which vary depending on the substrate. Many epidemiological studies have been performed to examine NQO1 polymorphism in tobacco-related cancers. These have shown that the NQO1 variant allele can modify the risk of colorectal cancer, lung cancer, renal cell carcinoma, and basal cell carcinoma (13-16).
###end p 5
###begin p 6
###xml 38 43 38 43 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GSTP1</italic>
###xml 48 52 48 52 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NQO1</italic>
###xml 298 303 298 303 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GSTP1</italic>
###xml 308 312 308 312 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NQO1</italic>
###xml 96 104 <span type="species:ncbi:9606">patients</span>
###xml 261 268 <span type="species:ncbi:4097">tobacco</span>
###xml 285 293 <span type="species:ncbi:9606">patients</span>
In the present study, we investigated GSTP1 and NQO1 polymorphisms, in a large series of Korean patients with HNSCC and in matched controls, to determine the association between genetic polymorphisms and HNSCC risk. We also assessed the association between the tobacco exposure of all patients and GSTP1 and NQO1 polymorphisms.
###end p 6
###begin title 7
MATERIALS AND METHODS
###end title 7
###begin title 8
Study subjects
###end title 8
###begin p 9
###xml 665 672 665 672 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T1">Table 1</xref>
###xml 886 893 886 893 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T1">Table 1</xref>
###xml 196 208 <span type="species:ncbi:9606">participants</span>
###xml 259 267 <span type="species:ncbi:9606">patients</span>
###xml 290 298 <span type="species:ncbi:9606">patients</span>
###xml 523 531 <span type="species:ncbi:9606">patients</span>
###xml 554 562 <span type="species:ncbi:9606">patients</span>
The study population consisted of 294 HNSCC cases and 333 cancer-free controls, recruited from the Department of Otolaryngology, at Asan Medical Center, from April 1994 to January 2004. All study participants were Korean. The case group consisted of 267 male patients (90.8%) and 27 female patients (9.2%); 251 cases were smokers with a mean age of 62 yr, and 43 were non-smokers with a mean age of 57 yr. Pathology reports were used to confirm the diagnosis of HNSCC for all cases. The control group consisted of 277 male patients (83.2%) and 56 female patients (16.8%); 312 were smokers with a mean age of 51 yr, and 21 were non-smokers with a mean age of 42 yr (Table 1). Controls were randomly selected from inpatients and outpatients with no history of cancer and were diagnosed with benign head and neck lesions. The distribution of primary cancer sites, among cases, is shown in Table 1.
###end p 9
###begin p 10
For study purposes, subjects were divided into non-smokers and ever-smokers. Ever-smokers were defined as anyone who had smoked at least one pack-year; a pack-year was defined as the product of [{number of cigarettes consumed per day}x{duration of smoking (years)}]. Ever smokers were grouped as mild (</=30 pack-years) and heavy (>30 pack-years) smokers. Non-smokers were defined as individuals who had smoked less than one pack-year. Informed consent was obtained from all study subjects prior to participation.
###end p 10
###begin title 11
Genotyping methods
###end title 11
###begin p 12
###xml 525 532 507 514 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T2">Table 2</xref>
After informed consent was obtained, each subject donated ten milliliters of blood. A B lymphocyte pellet, obtained from the buffy coat by centrifuging the whole blood, was used for DNA extraction using a DNA purification kit (GENTRA, Minneapolis, MN, U.S.A.). SNP genotyping was performed by SNP-ITtrade mark assays using the SNPstream 25Ktrade mark System (Orchid Biosciences, NJ, U.S.A.). The genomic DNA region spanning the polymorphic site was PCR amplified using one phosphothiolated primer and one regular PCR primer (Table 2). The amplified PCR products were digested with exonuclease. The 5'phosphothiolates protected one strand of the PCR product from exonuclease digestion, resulting in the generation of a single-stranded PCR template. The single-stranded PCR template was then overlaid onto a 384 well plate that contained covalently attached SNP-ITtrade mark primer extension, designed to hybridize immediately adjacent to the polymorphic site. Primer extension reaction was performed with the SNaPshot ddNTP Primer Extension Kit (Applied Biosystems, Foster City, CA, U.S.A.). To purify the product of the primer extension reaction, one unit of SAP (shrimp alkaline phosphatase) was added to the reaction mixture and was incubated at 37℃ for one hour, followed by fifteen minutes at 72℃ for enzyme inactivation. The DNA samples, containing the extension products and Genescan 120 Liz size standard solution, were added to Hi-Di formamide (Applied Biosystems). The mixture was incubated at 95℃ for five minutes, then placed on ice for another five minutes. It was then analyzed by electrophoresis in an ABI Prism 3700 Genetic analyzer. The results were analyzed using GeneScan and Genotyper software (Applied Biosystems).
###end p 12
###begin title 13
Statistical analysis
###end title 13
###begin p 14
###xml 25 30 25 30 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GSTP1</italic>
###xml 35 39 35 39 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NQO1</italic>
###xml 123 124 121 122 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 308 309 306 307 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 386 387 382 383 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 447 452 443 448 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GSTP1</italic>
###xml 457 461 453 457 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NQO1</italic>
###xml 597 602 593 598 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GSTP1</italic>
###xml 607 611 603 607 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NQO1</italic>
###xml 58 66 <span type="species:ncbi:9606">patients</span>
The distributions of the GSTP1 and NQO1 genotypes between patients and controls were compared using the Mantel-Haenszel chi2 test. The frequencies of genotypes were analyzed between the cases and the controls within three subgroups of wild type, heterozygote, and homozygote mutant. Throughout this study, a p-value of <0.05 was considered statistically significant. Mantel-Haenszel chi2 test was also used to evaluate the association between the GSTP1 and NQO1 genotypes and smoking status in HNSCC risk. The association between genotypes and smoking status was evaluated within subgroups of the GSTP1 and NQO1 genotypes, the wild type group and the combined heterozygote/homozygote mutant group.
###end p 14
###begin title 15
RESULTS
###end title 15
###begin p 16
###xml 0 7 0 7 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T3">Table 3</xref>
###xml 18 23 18 23 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GSTP1</italic>
###xml 28 32 28 32 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NQO1</italic>
###xml 106 111 106 111 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GSTP1</italic>
###xml 116 120 116 120 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NQO1</italic>
###xml 220 225 220 225 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GSTP1</italic>
###xml 230 234 230 234 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NQO1</italic>
###xml 311 313 311 313 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B17">17</xref>
###xml 572 579 572 579 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T3">Table 3</xref>
###xml 395 403 <span type="species:ncbi:9606">patients</span>
###xml 508 516 <span type="species:ncbi:9606">patients</span>
Table 3 shows the GSTP1 and NQO1 genotype distributions among cases and controls. The distribution of the GSTP1 and NQO1 genotypes among controls were in agreement with the Hardy-Weinberg equilibrium. The frequencies of GSTP1 and NQO1 genotypes in controls were similar to those previously observed in Koreans (17). When comparing the genotype distribution between control individuals and HNSCC patients, we observed that the frequency of the wild type GSTP1 and NQO1 genotype was slightly elevated in HNSCC patients, but the difference was not statistically significant (Table 3).
###end p 16
###begin p 17
###xml 0 5 0 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GSTP1</italic>
###xml 10 14 10 14 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NQO1</italic>
###xml 109 110 109 110 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 414 415 414 415 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 542 549 542 549 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T4">Table 4</xref>
###xml 584 588 584 588 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NQO1</italic>
###xml 785 792 785 792 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T5">Table 5</xref>
###xml 799 803 799 803 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NQO1</italic>
###xml 954 955 954 955 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1089 1096 1089 1096 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T4">Table 4</xref>
###xml 1098 1099 1098 1099 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T5">5</xref>
###xml 492 499 <span type="species:ncbi:4097">tobacco</span>
###xml 840 847 <span type="species:ncbi:4097">tobacco</span>
GSTP1 and NQO1 polymorphisms were associated with cigarette smoking and the risk of HNSCC in the case group (p<0.05). The frequency of genotype AA in GSTP1 Ile105Val was 83.7% in non-smokers, 70.1% in mild smokers, and 66.7% in heavy smokers; the frequency of the G allele containing genotypes (genotypes GA and GG) was 16.3%, 29.9%, and 33.3%, respectively. Genotype distributions were statistically significant (p=0.0114), and we observed that the GSTP1 105Val allele was associated with a tobacco dose-dependent increase in risk of HNSCC (Table 4). The frequency of genotype CC in NQO1 Trp139Arg was 100% in non-smokers, 98.7% in mild smokers, and 94.8% in heavy smokers, and the frequency of T allele containing genotypes (genotype TC and TT) was 0%, 1.3%, and 5.2%, respectively (Table 5). The NQO1 139Arg allele was associated with a tobacco dose-dependent increase in risk of HNSCC and these genotype distributions were statistically significant (p=0.0454). In the control groups, no significant difference of genotype distribution was found between wild type and mutant genotypes (Table 4, 5).
###end p 17
###begin title 18
DISCUSSION
###end title 18
###begin p 19
###xml 323 328 323 328 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GSTP1</italic>
###xml 333 337 333 337 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NQO1</italic>
###xml 459 464 459 464 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GSTP1</italic>
###xml 469 473 469 473 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NQO1</italic>
###xml 57 65 <span type="species:ncbi:9606">patients</span>
###xml 129 136 <span type="species:ncbi:4097">tobacco</span>
In this hospital-based, case-control study of 627 Korean patients, polymorphisms in two of the genes involved with metabolism of tobacco-induced carcinogens, GSTP1 Ile105Val and NQO1 Trp139Arg, were examined for association with HNSCC risk. We found no significant difference among the genotype distribution of polymorphic GSTP1 and NQO1 genes between HNSCC cases and controls. Although there are a large number of reports which suggest that polymorphisms of GSTP1 and NQO1 genes influence the susceptibility to cancer, the results of this present study suggest that the polymorphisms of the genes alone have only minor importance in the susceptibility to HNSCC. However, this finding is likely not due to the lack of a relationship between genetic polymorphisms and risk of HNSCC, but rather because biomolecular studies for genetic polymorphisms are still in the early phases of development.
###end p 19
###begin p 20
To date, the role of several different DNA polymorphisms in detoxification genes have been examined in numerous case-control HNSCC studies. Results have often been conflicting, and some report weak-to-moderate associations, while others show no elevation of risk. These conflicting results may be due to relatively small samples sizes, or the lack of proper controls for other environmental exposures that are also risk factors for HNSCC. This study is also limited by the relatively small number of cases and controls. And the control population in this study was a convenience sample, and cases and controls were not balanced for confounding factors, age and sex. Therefore further studies with a larger number of subjects and well controlled risk factors such as age, sex, smoking, and alcohol exposures are needed.
###end p 20
###begin p 21
###xml 143 145 143 145 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B18">18</xref>
###xml 494 501 <span type="species:ncbi:4097">tobacco</span>
In addition, the concept of genetic susceptibility is extremely complex and involves multiple cellular systems regulated by hundreds of genes (18), therefore, it is difficult to explain the association between genetic polymorphisms and risk of HNSCC by analyzing only one or two genes. In conclusion, a variety of analysis is needed, including a combined analysis of multiple polymorphic genotypes in detoxification enzymes, and of haplotypes to multiple enzymes associated with metabolisms of tobacco-induced carcinogens.
###end p 21
###begin p 22
###xml 17 22 17 22 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GSTP1</italic>
###xml 27 31 27 31 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NQO1</italic>
###xml 160 161 160 161 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 342 347 342 347 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GSTP1</italic>
###xml 352 356 352 356 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NQO1</italic>
###xml 472 477 472 477 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GSTP1</italic>
###xml 482 486 482 486 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NQO1</italic>
###xml 1427 1432 1427 1432 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GSTP1</italic>
###xml 1437 1441 1437 1441 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NQO1</italic>
###xml 652 659 <span type="species:ncbi:4097">tobacco</span>
###xml 786 793 <span type="species:ncbi:4097">tobacco</span>
In our analysis, GSTP1 and NQO1 polymorphisms were associated with the status of cigarette smoking and, therefore an increased risk of HNSCC in the case group (p<0.05). For evaluation of smoking and genetic polymorphisms, we divide the subjects into three subgroups: non-smokers, mild smokers, and heavy smokers. Frequencies of the wild type GSTP1 and NQO1 genotypes were high in all three subgroups compared to frequencies of the mutant allele containing genotypes. Both GSTP1 and NQO1 genotype distributions in all three subgroups of the cases were statistically significant, and the GSTP1 105Val allele and NQO1 139Arg allele were associated with a tobacco dose-dependent increase in risk of HNSCC. It is likely that because GSTP1 and NQO1 are involved in the metabolism of specific tobacco smoke intermediates, ever smokers with the variant alleles, which are associated with reduced enzymatic activities, experience deleterious effects from reduced carcinogen detoxification. Therefore, there is a greater impact on HNSCC risk in smokers based on pack-years of smoking. This suggests that a predisposition to genetic factors, such as GSTP1 and NQO1 variants, plays a role in the development of HNSCC in smokers. However, there were no significant differences in the distribution of genetic variants among the smoking status in controls. There was also no significant difference in the genotype distribution of polymorphic GSTP1 and NQO1 genes between HNSCC cases and controls. From this point of view, environmental effects such as cigarette smoking are likely to dominate over genetic effects.
###end p 22
###begin p 23
###xml 59 64 59 64 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GSTP1</italic>
###xml 159 161 159 161 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B19">19</xref>
###xml 359 361 359 361 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B20">20</xref>
###xml 396 401 396 401 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GSTP1</italic>
###xml 519 523 519 523 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NQO1</italic>
###xml 742 746 742 746 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NQO1</italic>
###xml 824 826 824 826 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B21">21</xref>
###xml 828 830 828 830 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B22">22</xref>
###xml 180 188 <span type="species:ncbi:9606">patients</span>
###xml 661 668 <span type="species:ncbi:4097">tobacco</span>
Several studies have examined the relationship between the GSTP1 polymorphisms and smoking status in HNSCC, and the results are not consistent. Ophuis et al. (19) found that HNSCC patients with the GSTP1 G allele containing genotypes (GA and GG) showed increased odds ratios for smoking compared with the wild type GSTP1 genotype. However, McWilliams et al. (20) found no association between the GSTP1 genotypes and smoking status in HNSCC risk. There are no studies performed to determine the relationship between the NQO1 polymorphisms and smoking in HNSCC. However, in bladder cancer, which is similar to HNSCC epidemiology in that it is strongly related to tobacco exposure, there are several studies that suggest the association between NQO1 genetic polymorphisms and the development of smoking related bladder cancer (21, 22).
###end p 23
###begin p 24
Assessment of smoking or alcohol consumption is difficult, especially for the total accumulative exposure. Exposure usually takes place over many years and is not always consistent. In addition, different cigarette brands may yield completely different nicotine and tar exposures. Therefore, development of biomarkers, that could indicate the level of exposure and the period of consumption, would be more helpful.
###end p 24
###begin p 25
###xml 511 516 511 516 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GSTP1</italic>
###xml 521 525 521 525 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NQO1</italic>
###xml 413 420 <span type="species:ncbi:4097">tobacco</span>
In summary, to study the effect of different genotypes on the risk of developing HNSCC, we conducted a case-control study of two genetic polymorphisms in HNSCC. We were unable to demonstrate a significant association between genetic polymorphisms and risk of HNSCC. However, in analysis of the association between smoking and genetic polymorphisms, GSTP1 105Val allele and NQO1 139Arg allele were associated with tobacco dose-dependent increase in risk of HNSCC in the case group. Our findings suggest that the GSTP1 and NQO1 genotype polymorphisms may play an important role in the development of HNSCC, and that the association between cigarette smoking and HNSCC may be modulated by these genetic polymorphisms.
###end p 25
###begin p 26
###xml 45 96 45 96 <funding-source xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">National R&amp;D Program for the Cancer Control Program</funding-source>
###xml 108 117 108 117 <award-id xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">0320320-2</award-id>
###xml 120 148 120 148 <funding-source xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ministry of Health &amp; Welfare</funding-source>
This study was supported by a grant from the National R&D Program for the Cancer Control Program (Grant No. 0320320-2), Ministry of Health & Welfare, Republic of Korea.
###end p 26
###begin article-title 27
Cancer statistics 1998
###end article-title 27
###begin article-title 28
Segregation analysis of squamous cell carcinoma of head and neck: evidence for a major gene determining risk
###end article-title 28
###begin article-title 29
Diagnosis of polymorphisms in carcinogen activating and inactivating enzymes and cancer susceptibility-a review
###end article-title 29
###begin article-title 30
Glutathione S-transferases; biomedical applications
###end article-title 30
###begin article-title 31
The glutathione S-transferase supergene family: regulation of GST and the contribution of the isoenzymes to cancer chemoprotection and drug resistance
###end article-title 31
###begin article-title 32
###xml 46 51 <span type="species:ncbi:9606">human</span>
Glutathione S-transferases and glutathione in human head and neck cancer
###end article-title 32
###begin article-title 33
Glutathione transferases and cancer
###end article-title 33
###begin article-title 34
###xml 55 71 <span type="species:ncbi:562">Escherichia coli</span>
###xml 102 107 <span type="species:ncbi:9606">human</span>
Molecular cloning, characterization, and expression in Escherichia coli of full-length cDNAs of three human glutathione S-transferase Pi gene variants. Evidence for differential catalytic activity of the encoded proteins
###end article-title 34
###begin article-title 35
The glutathione S-transferase GSTP1 polymorphism: effects on susceptibility to oral/pharyngeal and laryngeal carcinomas
###end article-title 35
###begin article-title 36
DT-diaphorase
###end article-title 36
###begin article-title 37
###xml 87 94 <span type="species:ncbi:50278|species:ncbi:153742">quinine</span>
NAD(P)H:quinone oxidoreductase 1 specifically prevents the formation of benzo[a]pyrene quinine-DNA adducts generated by cytochrome P450 1A1 and P450 reductase
###end article-title 37
###begin article-title 38
Purified NAD(P)H:quinone oxidoreductase 1 enhances the mutagenicity of dinitropyrenes in vitro
###end article-title 38
###begin article-title 39
The NAD(P)H:quinone oxidoreductase 1 gene polymorphism and lung cancer: differential susceptibility based on smoking behavior
###end article-title 39
###begin article-title 40
###xml 105 110 <span type="species:ncbi:9606">human</span>
Candidate genetic modifiers of individual susceptibility to renal cell carcinoma: a study of polymorphic human xenobiotic-metabolizing enzymes
###end article-title 40
###begin article-title 41
Association of NAD(P)H: quinone oxidoreductase (NQO1) null with numbers of basal cell carcinomas: use of a multivariate model to rank the relative importance of this polymorphism and those at other relevant loci
###end article-title 41
###begin article-title 42
NAD(P)H:quinone oxidoreductase-dependent risk for colorectal cancer and its association with the presence of K-ras mutations in tumors
###end article-title 42
###begin article-title 43
Influence of GST subfamily & NQO1 gene polymorphism on the metabolism of benzene
###end article-title 43
###begin article-title 44
DNA repair gene ERCC1 and ERCC2/XPD polymorphisms and risk of squamous cell carcinoma of the head and neck
###end article-title 44
###begin article-title 45
Polymorphisms of the glutathione S-transferase P1 gene and head and neck cancer susceptibility
###end article-title 45
###begin article-title 46
Genetic polymorphisms in head and neck cancer risk
###end article-title 46
###begin article-title 47
An association between NQO1 genetic polymorphism and risk of bladder cancer
###end article-title 47
###begin article-title 48
CYP2E1 and NQO1 genotypes, smoking and bladder cancer
###end article-title 48
###begin p 49
Frequency distribution analysis of demographic and risk factors
###end p 49
###begin p 50
Primers for amplification and sequencing of genes
###end p 50
###begin p 51
###xml 80 88 <span type="species:ncbi:9606">patients</span>
Genotype distribution of GST1 and NQO1 polymorphisms in squamous cell carcinoma patients and controls
###end p 51
###begin p 52
###xml 20 25 20 25 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GSTP1</italic>
Association between GSTP1 Ile105Val genotypes and smoking amounts
###end p 52
###begin p 53
PY, pack year.
###end p 53
###begin p 54
###xml 20 24 20 24 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NQO1</italic>
Association between NQO1 Trp139Arg genotypes and smoking amounts
###end p 54
###begin p 55
PY, pack year.
###end p 55

